Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Parkinson disease”

Study of Axial and Cognitive Symptoms and Biomarkers of Neurodegeneration in Brain-first and Body-first PDRecruiting
NCT07187843N/AUpdated Apr 23, 2026
Sponsor: Azienda USL Reggio Emilia - IRCCS
Parkinson Disease · Parkinsonian Disorders · Brain Disease · Basal Ganglia Diseases
Italy
A Phase 2a Multicenter Clinical Trial of TB006 in Participants With Parkinson's DiseaseActive Not Recruiting
NCT06773962Phase 2Updated Apr 23, 2026
Sponsor: TrueBinding, Inc.
Parkinson's Disease (PD)
United States
Intrapatient Comparison of STN and GPi tTIS in PDEnrolling By Invitation
NCT07018388NAUpdated Apr 22, 2026
Sponsor: Ruijin Hospital
Parkinson Disease
China
Predictive Factors and Subthalamic Stimulation in Parkinson's DiseaseCompleted
NCT02360683N/AUpdated Apr 22, 2026
Sponsor: University Hospital, Lille
Parkinson's Disease
France
Retinal Hyperspectral Imaging in Neurodegenerative DiseasesRecruiting
NCT07545473NAUpdated Apr 22, 2026
Sponsor: Center for Eye Research Australia
Dementia · Neurodegenerative Diseases · Alzheimer Disease · Parkinson Disease
Australia
Amyloid Monoclonal Antibody Treatment in PD Patients With Coexistent AD PathologyNot Yet Recruiting
NCT07544953NAUpdated Apr 22, 2026
Sponsor: Yonsei University
Parkinson Disease
South Korea
Safety Evaluation of Intravenous Talineuren (TLN) in Parkinson's Disease-affected PatientsTerminated
NCT04976127Phase 1Updated Apr 22, 2026
Sponsor: InnoMedica Schweiz AG
Parkinson Disease
Switzerland
rTMS to Improve Cognition in Parkinson'sRecruiting
NCT03836950Phase 1, Phase 2Updated Apr 21, 2026
Sponsor: VA Office of Research and Development
Parkinson's Disease · Mild Cognitive Impairment
United States
A Multi-Center Study of MYOBLOC for the Treatment of Sialorrhea in Parkinson's Disease PatientsCompleted
NCT00515437Phase 2Updated Apr 21, 2026
Sponsor: Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC
Drooling
United States
Efficacy and Safety Study of MYOBLOC® in the Treatment of Sialorrhea in Adult SubjectsCompleted
NCT01994109Phase 3Updated Apr 21, 2026
Sponsor: Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC
Sialorrhea
United States, Russia, Ukraine
A System to Help With Freezing of Gait in Parkinson's PatientsNot Yet Recruiting
NCT07542743NAUpdated Apr 21, 2026
Sponsor: Barron Associates, Inc.
Freezing of Gait Symptoms in Parkinson Disease
United States
Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease PatientsRecruiting
NCT07371338Phase 1Updated Apr 21, 2026
Sponsor: Innopeutics Corporation
Parkinson Disease · Parkinson's Disease
South Korea
Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's DiseaseCompleted
NCT05862649NAUpdated Apr 21, 2026
Sponsor: NeuraLight
Parkinson Disease
United States, Portugal, Spain, Switzerland, United Kingdom
rTMS Over the Dorsolateral Prefrontal Cortex for the Treatment of Impulse Control Disorders in Parkinson's DiseaseRecruiting
NCT06237868NAUpdated Apr 20, 2026
Sponsor: West Virginia University
Impulse Control Disorder · Parkinson Disease
United States
Remote Therapeutic Monitoring Exercise TrackingActive Not Recruiting
NCT06306768NAUpdated Apr 20, 2026
Sponsor: Shirley Ryan AbilityLab
Parkinson Disease · Multiple Sclerosis
United States
Effects of Cognitive Dual-Task on Gait in Parkinson's DiseaseNot Yet Recruiting
NCT07540325N/AUpdated Apr 20, 2026
Sponsor: Gazi University
Parkinson's Disease (PD) · Cognition · Gait Disorders
Turkey (Türkiye)
A Study of LY4006896 in Healthy Participants and Participants With Parkinson's DiseaseRecruiting
NCT06809400Phase 1Updated Apr 20, 2026
Sponsor: Eli Lilly and Company
Parkinson Disease
United States, Japan
Pain and Autonomic Symptoms in Parkinson's Disease and Atypical ParkinsonismsRecruiting
NCT05748028N/AUpdated Apr 17, 2026
Sponsor: Istituti Clinici Scientifici Maugeri SpA
Parkinson Disease · Multiple System Atrophy
Italy
To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor ComplicationsActive Not Recruiting
NCT06553027Phase 3Updated Apr 17, 2026
Sponsor: Cerevance
Parkinson Disease
United States, Australia, Czechia, France, Italy +4 more
First-in-Human Single and Multiple Dose of HL-400Recruiting
NCT06997484Phase 1Updated Apr 17, 2026
Sponsor: Highlightll Pharmaceutical (USA) LLC
Parkinson Disease
United States
The Swedish BioFINDER Sleep StudyRecruiting
NCT07533799N/AUpdated Apr 16, 2026
Sponsor: Skane University Hospital
Parkinson´s Disease · REM Sleep Behavior Disorder (iRBD) · Lewy Body Disease · Synucleinopathy
Sweden
Collaborative vs Non-Immersive VR in Parkinson's RehabilitationRecruiting
NCT07523425NAUpdated Apr 15, 2026
Sponsor: Superior University
Parkinson Desease
Pakistan
Resistant Maltodextrin for Gut Microbiome in Parkinson's Disease: Safety and Tolerability StudyActive Not Recruiting
NCT03667404Phase 2Updated Apr 15, 2026
Sponsor: Northwestern University
Parkinson Disease · Intestinal Bacteria Flora Disturbance · Dietary Modification
United States
Pembrolizumab (MK-3475) Plus Gemcitabine/Cisplatin Versus Placebo Plus Gemcitabine/Cisplatin for First-Line Advanced and/or Unresectable Biliary Tract Carcinoma (BTC) (MK-3475-966/KEYNOTE-966)-China Extension StudyCompleted
NCT04924062Phase 3Updated Apr 15, 2026
Sponsor: Merck Sharp & Dohme LLC
Biliary Tract Carcinoma
China
Phase 2a Study of VTX3232 in Parkinson's DiseaseCompleted
NCT06556173Phase 2Updated Apr 15, 2026
Sponsor: Zomagen Biosciences Ltd.
Idiopathic Parkinson Disease
United States

Previous page Next page